Pages that link to "Q29398804"
Jump to navigation
Jump to search
The following pages link to Plasma concentrations of chloramphenicol after subcutaneous administration to koalas (Phascolarctos cinereus) with chlamydiosis (Q29398804):
Displaying 18 items.
- Identification of MHCII variants associated with chlamydial disease in the koala (Phascolarctos cinereus). (Q33843268) (← links)
- A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus). (Q35891541) (← links)
- Chlamydia Serine Protease Inhibitor, targeting HtrA, as a New Treatment for Koala Chlamydia infection (Q37181409) (← links)
- In vitro activity of chloramphenicol, florfenicol and enrofloxacin against Chlamydia pecorum isolated from koalas (Phascolarctos cinereus). (Q37838973) (← links)
- Orchitis and Epididymitis in Koalas (Phascolarctos cinereus) Infected With Chlamydia pecorum. (Q37842101) (← links)
- Comparison of subcutaneous versus intranasal immunization of male koalas (Phascolarctos cinereus) for induction of mucosal and systemic immunity against Chlamydia pecorum (Q37842344) (← links)
- Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses. (Q37843628) (← links)
- Evaluation of enrofloxacin use in koalas (Phascolarctos cinereus) via population pharmacokinetics and Monte Carlo simulation. (Q37845550) (← links)
- Pharmacokinetics of chloramphenicol following administration of intravenous and subcutaneous chloramphenicol sodium succinate, and subcutaneous chloramphenicol, to koalas (Phascolarctos cinereus). (Q37847674) (← links)
- Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology (Q37849535) (← links)
- Assessment of florfenicol as a possible treatment for chlamydiosis in koalas (Phascolarctos cinereus). (Q38606119) (← links)
- Review of some pharmacokinetic and pharmacodynamic properties of anti-infective medicines administered to the koala (Phascolarctos cinereus). (Q39432406) (← links)
- Characterization of shifts of koala (Phascolarctos cinereus) intestinal microbial communities associated with antibiotic treatment. (Q52632506) (← links)
- Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. (Q55472927) (← links)
- Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus) (Q60920017) (← links)
- Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease (Q60932355) (← links)
- Physiological stress levels in wild koala sub-populations facing anthropogenic induced environmental trauma and disease (Q64115572) (← links)
- Genetic differences in Chlamydia pecorum between neighbouring sub-populations of koalas (Phascolarctos cinereus) (Q92250875) (← links)